HONG KONG, May 12, 2026 - (ACN Newswire via SeaPRwire.com) - May 11, 2026, Gold Peak Technology Group Limited (SEHK: 40) completed a syndicated green and sustainability-linked loan facility (the “GSLL Facility”) of HK$675 million with 10 major banks. With Hang Seng Bank Limited as the mandated lead arranger and bookrunner, Shanghai Commercial Bank Limited is the mandated lead arranger and Malayan Banking Berhad the lead arranger. Other arrangers include Chang Hwa Commercial Bank, Ltd. Hong Kong Branch; Bank of Dongguan International Limited; China Zheshang Bank Co., Ltd. Hong Kong Branch; Taiwan Cooperative Bank, Ltd. Hong Kong Branch; Taiwan Shin Kong Commercial Bank Co., Ltd., Hong Kong Branch; First Commercial Bank, Ltd., Macau Branch; and Hua Nan Commercial Bank, Ltd., Offshore Banking Branch.Notwithstanding the challenging global environment, this HK$675 million GSLL Facility underscores strong confidence and backing from the banking sector in Gold Peak’s commitment to, and track record of, upholding and advancing Environmental, Social, and Governance (“ESG”) principles.Victor Lo, Chairman & Chief Executive of Gold Peak, said, “Gold Peak remains steadfast in its commitment to long-term sustainable development and has consistently demonstrated its ability to deliver in this area. The establishment of the GSLL Facility not only validates our strategic direction but also enables us to explore innovative financing options and adopt operational best practices that will drive sustainable business growth.”Dr Brian Li, Vice Chairman and Executive Vice President of Gold Peak, commented, “As a prominent player in the batteries, audio, and electronics industries, Gold Peak is committed to embedding sustainability into every aspect of its operations. We have made solid and measurable progress in advancing our sustainability strategy, reflecting our dedication to responsible corporate citizenship and long-term value creation.”“We champion the use of rechargeable batteries to reduce waste. Our GP Recyko rechargeable range has been met with strong market acceptance, and we are continuously improving our charging efficiency to enable full charging in just one hour, a boost to shifting the consumers’ habit from single-use batteries to rechargeables.”“We continued to reinforce our packaging sustainability efforts by replacing plastic packaging with paper-based alternatives for more than 1,000 GP-branded consumer battery products across Europe. As a result of this initiative, we achieved an annual reduction of 48 tons of plastic and 30 tons of material waste.”GP Energy Tech, the Group’s sustainable energy solutions business, reached a key milestone with the opening of our first Nickel Zinc (NiZn) manufacturing facility in Dongguan, China, in January 2026. This marks an important step toward positioning Gold Peak to develop next- generation NiZn battery solutions, engineered to enhance immediate power performance through high power density, improved recyclability, and non-flammable characteristics.The NiZn batteries are designed to provide reliable, sustainable power for Uninterruptible Power Supply (UPS) systems for data centers and other critical infrastructures. Through the GSLL Facility, the Group will receive funding to further advance the NiZn initiative — supporting progress toward a safer and more sustainable future.Gold Peak views sustainability as a crucial value driver for achieving profitable, long-term growth. In FY24/25, it achieved a 4% year on year reduction in Scope 1 and Scope 2 greenhouse gas emissions compared to FY23/24 baseline year. It remains committed to its interim and long-term reduction targets as follows:- a 20% reduction by 2030 compared to the FY23/24 baseline;- a 60% reduction by 2040; and- the achievement of net-zero operational emissions (i.e., 100% reduction) by 2050.Among many sustainability awards, six of the Group’s battery manufacturing facilities have achieved Zero Waste to Landfill Platinum and Gold validation from UL Solutions, demonstrating its commitment to diverting 95-100% of waste from landfills through effective waste reduction and diversion strategies. Additionally, GP Batteries and GP Energy Tech have gained EcoVadis Bronze medal during FY25/26. The Group is also continuously ramping up the solar panels in factories to realize its decarbonization goals.Regina Lee, Head of Commercial Banking at Hang Seng Bank Limited, said, “This syndicated facility reflects the market’s confidence in Gold Peak’s long-term strategy and sustainability efforts. Hang Seng Bank is honoured to act as sole mandated lead arranger and bookrunner for a green and sustainability-linked loan facility, delivering a structure that incentivises performance against clear sustainability targets and supporting the Group’s continued investment in rechargeable battery manufacturing. Building on our long-standing relationship with Gold Peak, we’ll continue to work closely with the Group to align financing with sustainability outcomes, creating long-term value for stakeholders and the wider community.”The 3-year GSLL Facility features a tiered incentive mechanism that rewards progress toward sustainability targets, with Gold Peak eligible for an interest rate reduction upon achievement. Gold Peak plans to deploy the proceeds to further strengthen its financial position, accelerate the expansion of its rechargeable battery and sustainable energy solutions businesses, support long-term investment in advanced manufacturing technologies, drive operational excellence, and deepen its commitment to green and sustainable business practices.(Center) Brian Li, Vice Chairman and Executive Vice President of Gold Peak, signed the GSLL Facility of HK$675 million with 10 major banks.(7th from the left) Victor Lo, Chairman and Chief Executive of Gold Peak, expressed gratitude to the banks for their continued and unwavering support of the GSLL Facility.Gold Peak Technology Group Limited Charlotte WongSenior Manager, Corporate Communications Tel: (852) 2485 5328Email: charlotte_wong@goldpeak.comAJA Capital LimitedAvy Yu / Janet LouieTel: (852) 9500 4443 / (852) 9155 5615Email:avy.yu@ajacapital.com.hk / janet.louie@ajacapital.com.hkAbout Gold PeakGold Peak Technology Group is a global battery and electronics company with an aspiration to become one of the leaders in providing energy and sound solutions that enlighten and empower lives, and with sustainability as a focus.The parent company, Gold Peak Technology Group Limited (SEHK: 40), was established in 1964 and has been listed on the Stock Exchange of Hong Kong since 1984. Gold Peak holds a majority stake at 86.18%* in the Singapore-listed GP Industries Limited as its major industrial investment vehicle and operates manufacturing, R&D, marketing and distribution operations in more than 10 countries around the world.Gold Peak Technology Group Limited not only develops its consumer batteries, electronics and audio products, but also puts great emphasis on R&D of new rechargeable battery and B2B battery technologies. The Group has built renowned brand names for its major product categories, including GP batteries, GP Recyko batteries, KEF premium audio products and Celestion professional speaker drivers.www.goldpeak.com(* shareholding % as at 11 May 2026) Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 11, 2026 - (ACN Newswire via SeaPRwire.com) - The fifth International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC), opens today, featuring two flagship events. The sixth Asia Summit on Global Health (ASGH) is being held today and tomorrow (11 and 12 May) at the Hong Kong Convention and Exhibition Centre (HKCEC) under the theme “Fuelling Healthcare Breakthroughs”. The summit convenes over 90 influential international healthcare officials, research and medical experts, start-ups, investors, and business leaders from related industries to explore global healthcare trends, with a focus on frontier technologies, AI breakthroughs, pandemic preparedness, silver health, as well as innovation in Chinese medicine, in alignment with the National 15th Five-Year Plan. Another flagship event, the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair), also opens today (11 to 13 May) under the theme “Innovations Boosting Smart Health Experience”, featuring some 300 exhibitors from 10 countries and regions. The Fair spotlights MedTech, GeronTech and Preventive Healthcare, showcasing the latest medical innovations integrating artificial intelligence and robotics, fostering global exchange in healthcare innovation and reinforcing Hong Kong’s strengths as a research and commercial hub.Prof Frederick Ma, Chairman of the HKTDC, said in his welcome remarks: “There is nowhere better than Hong Kong, as a major international hub for financing and innovation, to explore areas of global collaboration in the health arena, and to showcase related business opportunities for investors and project owners. As a superconnector and super value-adder, Hong Kong has a long track record of helping companies and innovations break through. The theme we have adopted this year, ‘Fuelling Healthcare Breakthroughs’, highlights this vital role. The ASGH was created to nurture partnerships and knowledge exchange that can drive real change and create a better world. This year’s agenda also complements the healthcare priorities set out in China’s new 15th Five-Year Plan, supporting national development. Among the diverse topics at ASGH 2026 are sessions examining AI-enabled diagnosis and treatment, biomedical innovation, the growth of the silver health economy, traditional Chinese medicine and much more.”John Lee, Chief Executive of the HKSAR, said in his opening remarks: “Hong Kong, under the ‘one country, two systems’ principle, is investing in healthcare and, in doing so, investing in the future of our people and our economy. Our status as a leading hub for scientific innovation is unrivalled in Asia. And our strengths are magnified by our core position in the Guangdong-Hong Kong-Macao Greater Bay Area. That is the cluster city development integrating 11 dynamic cities in southern China. It boasts a collective economy that rivals that of the world's 10th-largest nation. In pursuit of medical innovation, Hong Kong complements the strategies set out in the National 15th Five-Year Plan. The Plan optimises an evaluation and approval mechanism for innovative drugs and supports their clinical application. The goal is to develop Hong Kong into a health and medical innovation hub. Central to this ambition is the rapid expansion of our clinical trial capabilities, the vital engine that drives biomedical R&D from the laboratory to the bedside.”Prof Zeng Yixin, Vice Minister of the National Health Commission of the People’s Republic of China, delivered special remarks: “Hong Kong has extensive experience in undergraduate medical education and post-graduate training, and enjoys a strong reputation in the Asia-Pacific region. Medical talent training system on the mainland is also undergoing deep reforms and striving to move towards high-quality development. Hong Kong has many experiences and practices that are worthy of in-depth exchange and reference, which will certainly promote mutual enhancement and progress.”Global leaders convene to explore collaboration opportunitiesThis morning’s Plenary Session I: Strengthening Pandemic Preparedness through Global Collaboration, featured keynote speech by Prof Lo Chung-mau, Secretary for Health of the HKSAR government, who said: “Hong Kong has long been recognised for the quality and efficiency of our healthcare system. We consistently rank at the top of global health indices, with a life expectancy that remains among the highest in the world, with women over 88 years and men about 83 years in 2024. Our public healthcare system serves as a robust safety net, ensuring universal health coverage for all at a very low cost. The National 15th Five-Year Plan calls for a health-first development strategy. Hong Kong is fully aligned and will continue to contribute to this national vision through our work in pandemic preparedness and medical innovation.”Prof Leo Poon, Daniel C K Yu Professor in Virology at the School of Public Health of the University of Hong Kong and Co-Director of the Hong Kong Jockey Club Global Health Institute, moderated the session. Distinguished speakers included Prof Ibrahim Abubakar, Vice-Provost (Health) and Professor of Infectious Disease Epidemiology at University College London; Feng Lan, Vice President, China Pharmaceutical Innovation and Research Development Association; Dr Leung Yiu-hong, Head of Emergency Response and Programme Management Branch, Department of Health of the HKSAR government; Dr Kumanan Rasanathan, Executive Director of the WHO Alliance for Health Policy and Systems Research; Prof Wang Yu, Chairman of the Chinese Foundation for Hepatitis Prevention and Control, also Former Director-General, Chinese Centre for Disease Control and Prevention; and Dr In-Kyu Yoon, Deputy Director General for Integrated Development and Pandemic Preparedness at the International Vaccine Institute. They discussed key strategies to strengthen the resilience of the global health system in response to future pandemics. Dr Kumanan Rasanathan said: “Public health agencies need to maintain scientific independence to synthesize, act upon, and provide advice based on the best available science. They also require operational flexibility because, during a pandemic or outbreak, it is not sufficient to rely solely on strategies used for previous outbreaks.”Plenary Session II: Fuelling Healthcare Breakthroughs was moderated by Victor Chu, Chairman and CEO of First Eastern Investment Group. Speakers included Clara Chan, CEO of Hong Kong Investment Corporation Limited; David Lau, Vice Chair of Investment Banking for Asia Pacific and Head of Healthcare Investment Banking for Asia Pacific at JP Morgan Securities; Dr Inna Menkova, Chief Executive Officer, Allogenica; Jonathan Symonds, Chairman of the Board of GSK; and Theresa Tse, Chairwoman of the Board, Sino Biopharmaceutical Limited; They examined investment trends and market transformation in biopharmaceuticals and explored how cross-sector collaboration can drive healthcare breakthroughs.One of the highlights this afternoon, the Dialogue with Global Pioneer in Health session, featured 2013 Nobel Prize laureate in Chemistry, Prof Michael Levitt, Robert W and Vivian K Cahill Professor in Cancer Research at Stanford University. He shared insights into his research and the future of technology-driven healthcare innovation, exploring how biological intelligence is shaping the future of healthcare. He said: “One of the secrets of successful evolution is to be as diverse as possible. This diversity then leads to intelligence.”Thematic sessions spotlight cutting-edge healthcare innovation and AI applicationsAs the global healthcare industry accelerates towards technology-driven transformation and industrial upgrading, multiple thematic sessions at the summit focus on the application of innovative technologies across the sector. Topics include AI-enabled healthcare, medical robotics and devices, cell and gene therapies, biomedical, and the silver economy, showcasing the latest market trends and aligning with the National 15th Five-Year Plan to advance the development of a “Healthy China” and foster AI and healthcare innovation. The first day featured a dedicated session, The Next Frontier in China's Healthcare Industry, moderated by Nisa Leung, Managing Partner of Aulis Capital, with speakers including Mark Gavin Lotter, Founder and CEO of Nuance Pharma; Wu Hao, Executive Director and Co-President of Tigermed; and Seth Zhang, Founder and CEO of MediTrust Health. They discussed strategies to drive the development of the Chinese Mainland healthcare sector. Wu Hao said: “By giving China-led industry data and applications greater exposure and participation on the global stage, Chinese enterprises can take a seat at the table and become true leaders.”Several thematic sessions spotlight the large-scale application of AI in healthcare. These include this afternoon’s sessions: Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution, moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and CEO of Gleneagles Hospital Hong Kong, featured speakers including Prof Joshua Ho, Assistant Dean (Innovation and Technology Transfer) in the Li Ka Shing Faculty of Medicine at the University of Hong Kong; and Reshaping Tomorrow’s Healthcare: Advances in Medical Robotics and Devices, further explored the transformative role of AI in medical robotics and next-generation medical devices, showcasing cutting-edge innovations and breakthrough developments. Tomorrow afternoon’s session, Transforming Healthcare through Digital Health & AI Innovations, with speakers from Healthtech Finland, Heidi Health, Pfizer, The Hong Kong Polytechnic University and other leading organisations, will offer multi-dimensional insight into AI applications and breakthroughs in the healthcare field.A new session this year, CSO Insights: Catalysing Scientific Breakthroughs and Investments for Future Health, will bring together leading scientists from global pharmaceutical companies, including Dr Li Xiang, Senior Vice President, Co-President and Chief Scientific Officer of Innovative Medicines Division at Fosun Pharma, to discuss transforming research breakthroughs into real-world healthcare applications.Building on last year’s Silver Health Chapter, tomorrow will feature the session Unlocking Growth in Silver Health: From Precision Medicine to Smart Ageing Innovations. Speakers include Prof Christopher Chao, Vice President (Research and Innovation) of the Hong Kong Polytechnic University; Prof Brian Kennedy, Director of the Centre for Healthy Longevity at the National University Health System, Singapore; and Zhang Junjie, Vice President of Ant Group and President of Healthcare Business Group. They will share insights into ageing-related disease prevention and solutions.Other sessions also cover a wide range of cutting-edge topics, including Driving Chinese Medicine Development Through Standardisation and Innovation, and IP Financing and Trading for Pharmaceutical and Health Technology. These thematic sessions examine the latest developments and trends in the healthcare industry from multiple perspectives, promoting exchanges among scientific research, market applications and industry policy. During the session From Detection to Cure: Accelerating Innovations for Rare Diseases, Prof Liang Zicai, Founder and Chairman of Suzhou Ribo Life Science, will explore how innovative diagnostics and treatments are bringing new hope to patients. Another session, Charting the Future: A New Era in Gene and Cell Therapies, brought together Dr Li Xiang, Founder and CEO of XellSmart, and Dr Zhu Tian, Co-founder and CEO of GenEditBio, who shared the latest advancements in stem cell biology and genome editing platforms with other guests. A global platform for healthcare resource matching, empowering pharmaceutical and healthcare companies to expand their businessIn addition to symposium sessions, some 180 healthtech companies from 12 countries and regions are showcasing innovative projects and solutions at the ASGH Business Hub and InnoHealth Showcase. At the same time, Project Pitching provides start-ups with opportunities to connect with investors, while the ASGH Deal-making facilitate one-on-one meetings to match global capital with healthcare projects. Participants can also access professional advice at the “GoGlobal Connect” and Business of Healthcare Advisory Zone, enabling companies to develop more targeted strategies for business expansion.Medical Fair showcases diverse AI-driven health solutions, with smart ageing products surge twofoldThe 17th Hong Kong International Medical and Healthcare Fair, organised by the HKTDC and co-organised by the Hong Kong MedTech Association, opened alongside ASGH. With the theme Innovations Boosting Smart Health Experience, the Fair brings together some 300 exhibitors from 10 countries and regions, including Hong Kong, the Chinese Mainland, Taiwan, Korea, as well as new participants from Macao, Australia, Canada, New Zealand, Vietnam and the United States, highlighting Hong Kong’s strengths as an international medical innovation hub.The Fair focuses on three key areas: MedTech, GeronTech and Preventive Healthcare, presenting a comprehensive showcase of the latest medical and healthcare equipment, products and application solutions from around the world. For MedTech, Neuroptek Corporation Inc from Canadian pavilion (Booth No.: 3E-D16) showcases the brand new EyeMirage, a solution that extends professional ophthalmic vision examinations beyond the clinic. By leveraging the computing power and camera technology of smartphones, the system enables users to conduct high-quality vision tests in settings such as homes and schools. Meanwhile, HKG epiTherapeutics Limited (Booth number: 3E-E06), from the Hong Kong Science and Technology Parks, presents a DNA methylation analysis technology designed for the early screening of liver cancer. The solution can identify and distinguish differential methylation features among liver cancer, blood and normal tissues. Its clinical research findings have been published in leading international academic journals[1], demonstrating a sensitivity of 88.5% for early-stage liver cancer and 95.7% for late-stage cases, representing one of the highest performance levels globally in methylation-based liver cancer early screening.In the field of GeronTech, the exhibits span a wide range of products, including smart rehabilitation robots, AI-powered mental health assessment systems, smart elderly care solutions and home-based care devices, fully addressing the evolving market needs of the silver economy. Hanshin Technology Limited (Booth No.: 3E-D13) introduces a Smart Shower Robot, which enhances safety and comfort for the elderly during bathing through intelligent design, while also easing caregivers’ workload and supporting the practical adoption of smart care solutions. Notably, the number of smart ageing products exhibited this year has more than doubled compared with the last edition, underscoring strong and growing market demand.In Preventive Healthcare, an exhibitor from Chinese Mainland, Guangzhou Supbio Bio-Technology and Science Co., Ltd. (Booth No: 3E-E19), presents the world’s first HIV-1 DNA quantitative testing kit approved for market launch by the National Medical Products Administration (NMPA). Designed to address increasingly complex HIV testing needs, the solution provides a stable and reliable full-disease-course testing approach, supporting an integrated and innovative model that spans prevention, treatment efficacy assessment and the exploration of functional cure through precision diagnostics.The Medical Fair features more than 50 themed forums and seminars, including topics such as “HKMTA Medical Fair Forum 2026: The Medtech Solutions - Greater Bay Area & Overseas”, co-organised with the Hong Kong MedTech Association, to be held tomorrow morning (12 May), followed by the afternoon session “ASEAN Gateway: Navigating Regulations, Capital and Distributions from Hong Kong”. On Wednesday (13 May), sessions such as “Decoding the Demand for Gerontechnology” will also take place. Industry experts will share the latest insights and market trends, and the exhibition will provide an ideal platform for professionals to network and explore new business opportunities. The exhibition will continue to adopt the “EXHIBITION+” hybrid model. The physical fair will take place from 11 to 13 May at the HKCEC. Global exhibitors, industry professionals, and buyers can engage in discussions via the “Click2Match” smart business matching platform from 4 May until 20 May.Photo download: https://bit.ly/4tsy9JsThe sixth Asia Summit on Global Health, jointly organised by the HKSAR government and the Hong Kong Trade Development Council, is held from 11 to 12 May at the Hong Kong Convention and Exhibition Centre under the theme “Fuelling Healthcare Breakthroughs.”Prof Frederick Ma, HKTDC Chairman, delivered the welcome remarks.John Lee, Chief Executive of the HKSAR, delivered the opening remarks.Prof Michael Levitt, 2013 Nobel Laureate in Chemistry, and the Robert W and Vivian K Cahill Professor in Cancer Research at Stanford University, shared his insight.ASGH Deal-making has facilitated one-on-one meetings, both online and offline, to channel capital to healthcare projects and promote collaboration.The ASGH Business Hub and InnoHealth Showcase have featured around 180 healthtech companies from 12 countries and regions.Under the theme Innovations Boosting Smart Health Experience, the 17th Hong Kong International Medical and Healthcare Fair (Medical Fair) highlights MedTech, GeronTech & Preventive Healthcare, with some 300 exhibitors from 10 countries and regions.On the first day of the Medical Fair, a series of forums and seminars were held, including “Digital Pulse, Preventive Future: When Wearable Technology Meets Chinese and Western Medicine Collaboration and AI” .The session featured Mr. Paul Anthony Yuen, Director of Dayton Industrial Co., Ltd., who joined academic experts in sharing insights into the latest developments in the field.Led by the Hong Kong Science and Technology Parks Corporation (HKSTP), DRESIO Limited showcases its AI-powered physiotherapy motion analysis system.Exhibitor from Canada bring medical technologies, highlighting clinical applications and solutions.Medical Fair exhibitor Green Life Technology Ltd (Booth No.: 3D-D24) showcases the world’s first product integrating inversion technology and 3D resonance technology, which has been successfully adopted by massage practitioners and therapists in Germany.WebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enThe Asia Summit on Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/en?ref_source=GrayMenu&ref_medium=vep-conferenceHong Kong International Medical and Healthcare Fair: https://www.hktdc.com/event/hkmedicalfair/en?ref_source=GrayMenu&ref_medium=vep-tradeshowList of Product: https://www.hktdc.com/event/hkmedicalfair/en/product?ref_source=GrayMenu&ref_medium=vep-tradeshowMedia enquiriesYuan Tung Financial Relations:Jasmine Zhang Tel: (852) 3428 3278 Email: jzhang@yuantung.com.hkLouise Song Tel: (852) 3428 5691 Email: lsong@yuantung.com.hkTiffany Leung Tel: (852) 3428 2361 Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Noah Qiu Tel (852) 2584 4575 Email: noah.yl.qiu@hktdc.orgNavin Law Tel: (852) 2584 4525 Email: navin.cm.law@hktdc.orgJane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. [1] The product was published in the world-leading academic journal Nature Communications (2023). Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, May 11, 2026 - (ACN Newswire via SeaPRwire.com) - Managing daily expenses can feel overwhelming, especially when bills, subscriptions, and lifestyle spending happen across different platforms. However, organising payments strategically using credit cards and cashbacks, and structured spending habits can help unlock better control, higher cashback, and long-term savings. In Singapore, where digital payments are widely accepted, aligning expenses smartly can help turn routine spending into value-earning opportunities.Unplanned spending often results in missed reward opportunities and unnecessary fees. When payments are scattered across multiple methods, tracking expenses becomes difficult, and potential cashback categories may go underutilised.In 2023, the average monthly household expenditure in Singapore was SGD 5,931. When monthly recurring payments are aligned under suitable cards, even a modest cashback rate of 1.5-5% can add up meaningfully over time.If you are looking to make the best use of your cashback credit cards and maximise your savings, here are some tips that you might find useful.Understand your monthly spending categoriesBefore selecting or using credit cards strategically, it helps to map out where money is being spent each month. This exercise can help distinguish between fixed recurring expenses and flexible lifestyle spending. With digital payments now a common part of daily life, small expenses can add up quickly without you noticing.Typical monthly spending categories may include groceries, transport, dining, utilities, mobile bills, insurance premiums, and online shopping. On average, Singaporeans spend around SGD 455 per month on food and groceries alone and an additional SGD 128 per month on public transport.When these categories are clearly defined, it is easier to identify which expenses qualify for cashback and which do not.Match the right Credit Card to the right expenseDifferent credit cards are designed to reward different types of spending. Some cards focus heavily on dining and entertainment, while others provide higher cashback on groceries, transport, or online purchases.For example, one card may offer 5% cashback on dining capped at SGD 50 monthly, while another provides 3-4% on online shopping and subscriptions. When all expenses are charged randomly to a single card, these benefits may remain underutilised.Assigning specific cards to specific expense categories can help structure spending without increasing it. This method allows users to stay within cashback limits, reduce confusion, and improve the efficiency of rewards across everyday transactions.Automate recurring bills for consistent cashbackAutomating recurring payments can help maintain consistency in both budgeting and cashback accumulation. Many essential services support automatic card payments, including utilities, broadband, mobile plans, and digital subscriptions.Automation also reduces the risk of missed due dates and late payment fees.Use cashback earned in practical waysCashback earned through credit card usage can be more useful when applied intentionally rather than treated as incidental savings. Instead of viewing it as extra money, cashback can help offset regular expenses and improve monthly cash flow. When planned properly, even small amounts earned each month can support everyday budgeting.Some practical ways cashback may be used include:Offsetting utility or telco billsHousehold expenses such as electricity, water, mobile, and broadband form a significant portion of regular monthly spending. Cashback credited to the card statement can reduce these fixed expenses directly, helping stabilise monthly outflow.Reducing grocery spendingUsing cashback to offset statement balances can help cover weekly grocery and essentials from supermarkets, easing the impact of rising grocery costs.Covering transport expensesMRT travel, ride-hailing services, and fuel expenses can be a big expense if not planned well. Cashback can be redirected towards SimplyGo top-ups or occasional Grab rides, helping manage daily commute costs.Supporting annual or seasonal expensesAccumulated cashback from payments may help offset insurance premiums, travel bookings, or festive shopping, reducing the pressure of large one-time payments. Used consistently, cashback can quietly strengthen everyday financial planning without changing spending habits.Align large purchases with reward periodsLarger purchases, such as electronics, furniture, or travel bookings, can sometimes be planned around bank promotional periods. In Singapore, many credit card providers run limited-time campaigns during events like the Great Singapore Sale, year-end holidays, or major online shopping festivals. During these periods, users may receive additional cashback, higher reward caps, or bonus returns on select categories, subject to promotional terms and conditions.Aligning such spending with promotional windows can help convert unavoidable costs into reward-generating transactions. Over time, this approach can support better savings outcomes while keeping overall spending controlled.Final thoughtsOrganising payments thoughtfully can help transform daily expenses into meaningful rewards. By aligning spending categories, automating bill payments, tracking spending limits, and using cashback strategically, Singapore consumers may find greater value in routine transactions.While results vary based on lifestyle and spending patterns, a structured approach can help create clarity, flexibility, and small yet steady savings over time. With the right planning, cashback and credit cards can become practical tools that support smarter money management rather than complicate it.Disclaimer: This content is published by iQuanti Singapore Pte. Ltd., an external marketer engaged and compensated by UOB Ltd.Contact Information:Name: Sonakshi MurzeEmail: Sonakshi.murze@iquanti.comJob Title: ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BRISBANE, AUS, May 11, 2026 - (ACN Newswire via SeaPRwire.com) - Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce GMG's energy saving and anti-corrosion graphene coating solution, THERMAL-XR, is being applied to the air conditioners for two luxury towers in Australia currently under construction at the Gold Coast in Queensland (the "Project"). The Project includes spraying THERMAL-XR on a total of between 300 to 600 air conditioners, see Figure 1 showing how the THERMAL-XR is sprayed on the air conditioners in GMG's spray booth facility in Brisbane Queensland.Figure 1: Spray Booth and Curing Area for Air Conditioners for ProjectTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/296885_3b33c46414878a4d_001full.jpgCraig Nicol, CEO & Managing Director of the Company, commented "Great to see two of the largest towers in Australia using THERMAL-XR on their air conditioners to save energy for the apartment owners and tenants as well as limiting corrosion and extending the air conditioners' life."Jack Perkowski, Non-Executive Chairman and Director of the Company, commented: "This project is a great demonstration of the commercial momentum THERMAL-XR is building in the Australian market. Seeing our graphene coating applied to up to 600 air conditioners across two of Australia's most prestigious luxury towers is a significant milestone - not only for the energy savings and extended asset life it is expected to deliver to apartment owners and tenants, but as a compelling proof point for the broader HVAC-R industry. Projects of this scale highlight the real-world value that GMG's technology brings and reinforce our path to building a substantial revenue base from our energy savings products."Figure 2To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/296885_gmgfigure2.jpgAbout THERMAL-XR® ENHANCE powered by GMG Graphene: THERMAL-XR® ENHANCE coating system is a unique patent product and method of improving the conductivity of heat exchange surfaces (including for air conditioners, refrigeration systems, heat pumps and data centres) and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces from corrosion (successfully passed up to 20,000 hours of salt sea spray corrosion testing) while improving the corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed at improving the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "believes" "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, THERMAL-XR coating on the Project's air conditioners, the energy savings, anti-corrosion and extension of asset life attributes of THERMAL-XR, the momentum THERMAL-XR is experiencing in Australia, the ability of GMG's energy savings products to build a revenue base, GMG's intentions to develop commercial scale-up capabilities, GMG's focus in the energy savings segment, GMG's intentions for the use of graphene lubricant additive on saving liquid fuels, expectations for R&D and commercialization of G+AI Batteries, GMG's ability to improve the performance of lithium-ion batteries and GMG's critical business objectives.Such forward-looking statements are based on a number of assumptions of management, including the coating of air conditioners on Meriton's two towers. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation that GMG does not receive or receive on a timely basis the fully signed consent notice from the and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 4, 2025 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296885 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月11日 - (亚太商讯 via SeaPRwire.com) - 联合评级国际有限公司（"联合国际"）近日发布跟踪评级结果，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"，股份代号：1788.HK）旗下全资资管平台——国泰君安资产管理（亚洲）有限公司所管理的两只基金：国泰君安港元货币市场基金与国泰君安美元货币市场基金，双双维持"AAAmf"货币市场基金("MMF")评级，充分展现了国泰君安国际在境外现金管理领域具备行业领先的专业能力与卓越的风险控制水平。本次获评"AAAmf"评级的两只基金均于2023年4月在香港注册成立，分别以港元及美元计价，专注为机构、企业及个人投资者提供高安全性、高流动性、稳健回报的现金管理工具，投资目标为追求与相关货币市场利率相一致的稳定回报。联合国际依据《货币市场基金评级准则》（2024年2月1日发布），从资产质量、信用水平、流动性管理、期限结构、风险控制等多个核心维度开展全面跟踪评审，最终确认两只基金均持续满足"AAAmf"评级标准，代表基金具备极强的流动性保障与本金安全能力，亦是国际评级体系对货币市场基金的最高评价。评级结果显示，两只基金在多方面表现突出，完全契合最高评级要求：一是资产质量优良，信用风险严控。基金主要投资对应币种短期存款及优质货币工具，资产加权平均信用质量达 BBB + 以上高投资级，集中度风险管控到位，并持续监控目标信用状况；二是流动性管理稳健，申赎保障充足。基金流动性充裕，可有效应对申赎需求。同时，组合久期严控，加权平均到期日低于 60 天、加权平均期限低于 120 天，市场风险处于较低水平；三是风控体系严谨，汇率风险有效对冲。基金衍生品仅用于对冲，非本币资产均对冲为基金计价货币，货币风险管理严谨，运作稳健可控。此次两只货币基金同获"AAAmf"评级，是国际权威评级机构对国泰君安国际及旗下资管平台投资管理能力、风险控制体系、产品运作规范性的高度认可，进一步彰显了公司在离岸现金管理领域的领先地位。近年来，全球市场波动加剧，低风险、高流动性的现金管理工具需求持续攀升，两只高评级货币基金凭借安全性高、流动性强、运作透明的优势，已成为离岸市场港元、美元现金管理的标杆选择，为投资者跨境资产配置提供坚实的"安全垫"。国泰君安资产管理（亚洲）有限公司作为国泰君安国际全资子公司，依托国泰海通集团的强大股东背景与综合金融实力，深耕香港及离岸资产管理市场，为全球客户提供覆盖固定收益、货币市场、多元资产等领域的专业资产管理服务。公司坚持稳健合规、专业精进的理念，搭建覆盖投研、风控、运营的全流程管理体系，凭借对离岸市场的专业研判与丰富运作经验，打造出一系列适配机构资金、企业闲置资金、高净值客户现金管理需求的优质产品。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK），是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高质量、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的信息请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月11日 - (亚太商讯 via SeaPRwire.com) - 今日，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"，股份代号：1788.HK）作为联席保荐人、保荐人兼整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人，携手集团旗下海通国际共同助力深圳乐动机器人股份有限公司（简称"乐动机器人"，股票代码：1236.HK）在香港交易所主板成功上市，展现出国泰海通以金融赋能高新技术企业国际化发展的卓越能力。 此次发行最终定价为每股26.36港元，总发售股数达33,333,400股，总集资额约为8.8亿港元，充分反映了市场对乐动机器人在视觉感知技术解决方案领域领先地位及未来增长潜力的高度认可。在项目推进过程中，国泰海通充分发挥跨境一体化投行服务体系优势，依托旗下子公司在跨境资本市场的专业能力以及对行业的深入理解，为乐动机器人提供全方位资本市场支持。国泰君安国际作为项目的核心参与方，凭借对智能机器人赛道的前瞻性布局与贯穿全程的专业服务，为乐动机器人的跨境资本运作注入了关键助力。本项目的高效执行与顺利完成，亦体现了国泰君安国际以一站式跨境金融服务助力中国高新技术企业扬帆国际资本市场的积极作为与专业实力。未来，国泰君安国际将在集团的带领下，继续秉持金融服务实体经济的初心，积极发挥综合金融服务能力与境内外资源整合优势，以专业投行能力赋能更多高新技术企业扬帆国际资本市场。关于乐动机器人乐动机器人成立于2017年，是一家提供视觉感知产品及割草机器人的公司，业务覆盖多款智能机器人激光雷达创新产品。根据招股文件，视觉感知产品是企业第一增长曲线，2025年搭载企业视觉感知技术的智能机器人超过900万台。同年，DTOF激光雷达出货量超过400万台，位居行业首位。而智能割草机器人的场景适应性与环境感知水平不断提升，已成为第二增长曲线，第一代产品于2024年量产并实现销售突破10,000台，第二代产品于次年量产。乐动机器人总部位于中国，正战略性扩大在海外市场的业务布局，积极在新加坡、德国等地设立运营中心，在越南建立生产合作关系，以实现海外研发、生产、销售及服务的高效协同。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK）,是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高品质、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的资讯请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com